Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Acta Dermato-Venereologica|May 6, 2024
Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated with UpadacitinibShawn G Kwatra, Marjolein De Bruin-Weller, Jonathan I Silverberg, et al.
The British Journal of Dermatology|December 11, 2025
Topical Steroid Withdrawal (TSW) Syndrome: Developing Diagnostic Criteria through a Modified Delphi MethodCynhia Hsu, Lily Guo, Derrick Adams, et al.
Pediatric Dermatology|March 7, 2013
Therapeutic patient education in children with atopic dermatitis: position paper on objectives and recommendationsSébastien Barbarot, Claire Bernier, Mette Deleuran, et al.
The Journal of Clinical and Aesthetic Dermatology|December 19, 2025
Nemolizumab Demonstrates Marked Efficacy in Challenging Chronic Pruritus: A Real-world Multicenter Case SeriesDiego Ruiz Dasilva, Alondra Soto-González, Nicholas K Mollanazar, et al.
Dermatology and Therapy|August 9, 2024
Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab TreatmentJonathan I Silverberg, Andreas Wollenberg, Linda Stein Gold, et al.
Journal of Drugs in Dermatology : JDD|July 2, 2024
Appearance Dissatisfaction and Body Dysmorphic Disorder in the Dermatology PatientZane Sejdiu, Erin Stitzlein, Evan A Rieder, et al.
Journal of the American Academy of Dermatology|December 21, 2024
The association between obesity and efficacy of psoriasis therapies: An expert consensus panelJoshua Burshtein, April Armstrong, May Chow, et al.
The Journal of Clinical and Aesthetic Dermatology|February 6, 2026
PDE4 Inhibitor-Responsive Dermatoses: An Emerging Concept in DermatologyCourtney A Chau, Hilary E Baldwin, James Q Del Rosso, et al.
Pediatric Dermatology|February 15, 2013
Therapeutic patient education in atopic dermatitis: worldwide experiencesJean-Francois Stalder, Claire Bernier, Alan Ball, et al.
JAMA Dermatology|August 4, 2021
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical TrialAndrew Blauvelt, Henrique D Teixeira, Eric L Simpson, et al.
Pageof 9